IL-6 is now available on several automated diagnostic platforms and can be easily analyzed even in an emergency and the targeted reduction of its activity by Tocilizumab has been demonstrated a good opportunity in COVID-19 patients [24]. The gene discussed is IL6; the disease is COVID-19.